XBI the ETF for Biotechnology LONG
Actualizado
Biotechnology is expected to be a hot subsector this year as healthcare recovered further from
the COVID pandemic anything from startups to big pharma- from vaccines to new drugs for
diabetes, liver disease and obesity. This is shown on a weekly chart to show the long term trend
with XBI pivoting to bullish back in early November. I add long positions when I see a dip
on the 3-4hr chart. My targets are the fib retracement expectation at 116 confluent with
the first upper VWAP band line and then the 135-138 zone underneath the second upper line
shown in thin red on the chart. This ETF smooths out the volatility characteristic of some
of the smaller biotechnology firms making it safer albeit with lesser rewards expectations.
Positions in NVAX and MRNA are having a good start to the week and will reflect in a small
way in this ETF which has broad constituent stocks within its portfolio.
the COVID pandemic anything from startups to big pharma- from vaccines to new drugs for
diabetes, liver disease and obesity. This is shown on a weekly chart to show the long term trend
with XBI pivoting to bullish back in early November. I add long positions when I see a dip
on the 3-4hr chart. My targets are the fib retracement expectation at 116 confluent with
the first upper VWAP band line and then the 135-138 zone underneath the second upper line
shown in thin red on the chart. This ETF smooths out the volatility characteristic of some
of the smaller biotechnology firms making it safer albeit with lesser rewards expectations.
Positions in NVAX and MRNA are having a good start to the week and will reflect in a small
way in this ETF which has broad constituent stocks within its portfolio.
Nota
Nice gain to begin the week. Will close 5% of the position to be deployedinto a long-term call option into 2026 on NVAX which is reporting and
recently settled a litigation matter that weighed it down for a long
time. Will add back to XBI position when the price settles down
to the liquidity-adjusted moving average.
Operación activa
XBI is trading well with a good gain so far this week. 5% of position of a lot of call options closed- these options are spread across time. the ones expiring at the March monthly are trimmed. Profits will be deployed into call options out of the moneyin 2026 on NVAX.
Operación activa
XBI up 5% for the week with lots of volatility along the way. I am daytrading the volatility to get daily profits to fund buying additional call options expiring 4-6 months out. Nota
Updated chart showing consolidation range right now Nota
Price is on support- i will buy next Monday a good sized add after the 3 day weekend. Operación activa
XBI moving up from a down trend. Going long with a midium sized position LABU and PILL also.Nota
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.